Clinical trial
RAFF5 Proposal: Project to Improve the Quality and Safety of the Immediate and Subsequent Care of Patients Seen in the Emergency Department With Acute Atrial Fibrillation and Flutter
NCT05468281 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RAFF5 Proposal: Project to Improve the Quality and Safety of the Immediate and Subsequent Care of Patients Seen in the Emergency Department With Acute Atrial Fibrillation and Flutter
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- July 30, 2023
- Enrollment
- 1,108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.